Latest News - Personnel/Company News

Thursday, February 23, 2017 | Personnel/Company News, Product Launches and Updates, Obagi, Valeant NJ

Obagi Medical Products Collaborates with Suzan Obagi, MD and Nextcell Medical to Introduce New Line

Valeant Pharmaceuticals International, Inc.’s wholly owned subsidiary Obagi Medical Products collaborated with Nextcell Medical Company to claim exclusive distribution of Suzan Obagi, MD’s…

Read the full story

Monday, February 20, 2017 | Personnel/Company News,

Suzanne Olbricht, MD, Named New Chief of Dermatology at Beth Israel Deaconess Medical Center

Suzanne Olbricht, MD, is the new Chief of Dermatology at Beth Israel Deaconess Medical Center (BIDMC) in Boston. She will also serve as President of the American Academy of Dermatology in 2018. …

Read the full story

Tuesday, February 14, 2017 | Personnel/Company News,, Cosmeceuticals, Revision Skincare

Ray Canole is New Chief Commercial Officer at Revision Skincare

Revision Skincare has announced the appointment of Ray Canole to the position of Chief Commercial Officer. He has over 15 years of business development and commercial related experience in d…

Read the full story

Tuesday, February 14, 2017 | Acquisitions and Mergers, Personnel/Company News,, Cosmetic surgery, Cynosure

Hologic to Acquire Cynosure

Hologic, Inc.  and Cynosure, Inc. have signed a definitive agreement for Hologic to acquire all outstanding Cynosure shares for $66.00 per share in cash, which corresponds to an eq…

Read the full story

Friday, February 10, 2017 | Personnel/Company News

Crescita Therapeutics Announces Management and Board Changes

Crescita Therapeutics Inc., a commercial dermatology company with a portfolio of over-the-counter and prescription products for the treatment and care of skin diseases and their symptoms, introduced M…

Read the full story

Wednesday, February 01, 2017 | Healthcare Trends, Personnel/Company News,,, Research and Publications

Medical Spa State of the Industry Statistical Study Now Open

During the past five years, the medical spa industry has grown and evolved to a point where it has become one of the most exciting and lucrative new industries in the country. Because of this, it is n…

Read the full story

Wednesday, February 01, 2017 | Personnel/Company News, Valeant NJ

Valeant Dermatology to Award $10,000 Scholarships for Undergraduate and Graduate Degrees

Valeant Dermatology, a division of Valeant Pharmaceuticals North America LLC, will award nine individual scholarships of up to $10,000 through its annual ASPIRE HIGHER Scholarship Program. The scholar…

Read the full story

Friday, January 27, 2017 | Personnel/Company News, Phase 3/4 Trials,, Research and Publications, Novan

Topline Results from Novan's SB204 Phase 3 Pivotal Trials: Inconsistent Across Trials

Novan, Inc. (NASDAQ:NOVN) today announced  top-line results from the Company’s two, replicate Phase 3 pivotal clinical trials for SB204 in the treatment of acne vulgaris. In the intent-to-t…

Read the full story

Monday, January 23, 2017 | Personnel/Company News,, BioPharmX Corporation, BioPharmX Corporation

Specialty Pharma Industry Vet Charles Gregory Vontz Joins BioPharmX Board of Directors

Charles "Greg" Vontz  is joining rhe Board of Directors of BioPharmX Corporation as an independent director, effective as of Jan. 17.  Vontz's appointment expands the board …

Read the full story

Wednesday, January 18, 2017 | Personnel/Company News,,

First Patient Treated in Dermata Therapeutics Phase 2 Acne Rosacea Clinical Study

The first patient has been dosed in Dermata Therapeutics’s Phase 2 acne rosacea study of DMT210, a topical gel specifically developed to downregulate the proinflammatory cytokines in the skin re…

Read the full story

Tuesday, January 17, 2017 | Personnel/Company News,,, Research and Publications, ISDIN

ISDIN: Broad Spectrum Sun Protection Cream with DNA Repair Beneficial Post AK Treatment

ISDIN has reported promising results of a 9-month, randomized, investigator-blinded parallel-group study in a poster presentation at the Winter Clinical Conference. The study was design…

Read the full story

Tuesday, January 10, 2017 | Personnel/Company News,, Product Launches and Updates, Valeant NJ

L'Oréal Buys CeraVe, AcneFree and AMBI from Valeant

Valeant Pharmaceuticals International, Inc. is selling CeraVe, AcneFree and AMBI skincare brands to L'Oréal for $1.3 billion in cash. The transaction is expected to close in th…

Read the full story

Friday, December 30, 2016 | Personnel/Company News,, Skin Cancer Foundation

Skin Cancer Foundation: Bill Ridenour Is New Senior Director of Partnership Development

The Skin Cancer Foundation has appointmented Bill Ridenour to the role of senior director of partnership development. Ridenour’s career has spanned over 30 years in the advertising industry…

Read the full story

Friday, December 30, 2016 | Personnel/Company News

Provectus Biopharmaceuticals Terminates CEO and COO

Provectus Biopharmaceuticals, Inc.'s Board of Directors unanimously voted to terminate Peter R. Culpepper, effective immediately, from all positions held with the company, including Chief Executiv…

Read the full story

Tuesday, December 27, 2016 | Personnel/Company News,,, Product Launches and Updates, La Roche-Posay

La Roche-Posay Nabs 20 Beauty Awards in 2016

La Roche-Posay (LRP) won 20 beauty awards, almost doubling its wins from the previous year, the company has announced. The awards, judged by editors, industry leaders and elite experts who test thousa…

Read the full story
Load More